Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-21-251540
Filing Date
2021-08-19
Accepted
2021-08-19 16:23:29
Documents
5
Period of Report
2021-10-07

Document Format Files

Seq Description Document Type Size
1 PRE 14A d147289dpre14a.htm PRE 14A 522313
2 GRAPHIC g147289g01v01.jpg GRAPHIC 16143
3 GRAPHIC g147289g02c02.jpg GRAPHIC 6705
4 GRAPHIC g147289g10r12.jpg GRAPHIC 24294
5 GRAPHIC g147289g82l95.jpg GRAPHIC 13033
  Complete submission text file 0001193125-21-251540.txt   606591
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: PRE 14A | Act: 34 | File No.: 000-17988 | Film No.: 211190368
SIC: 2835 In Vitro & In Vivo Diagnostic Substances